Pistono Massimo, Giordano Andrea, Gnemmi Marco, Gambarin Fabiana Isabella, Granata Mario, Imparato Alessandro, Temporelli Pier Luigi, Mannucci Letizia, Prolo Silvia, Corrà Ugo
Istituti Clinici Scientifici Maugeri IRCCS, Cardiology Rehabilitation Unit of Gattico-Veruno Institute, Gattico-Veruno, Italy.
Istituti Clinici Scientifici Maugeri IRCCS, Bio-Engineering Service of Gattico-Veruno Institute, Gattico-Veruno, Italy.
Artif Organs. 2025 May;49(5):886-893. doi: 10.1111/aor.14940. Epub 2025 Jan 10.
Left Ventricular Assist Device (LVAD) implantation is an important treatment option for patients with advanced CHF. Referral to an early, intensive cardiac rehabilitation (CR) program in these patients seems still underused. This observational descriptive study aimed to evaluate the feasibility and efficacy of an early intensive CR program in LVAD recipients, also comparing results with a matched group of advanced HFrEF patients.
The study involved patients with LVAD implantation due to HFrEF who were admitted to our intensive post-acute CR program from several surgery wards from 2009 to 2023. They underwent a twice-a-day individualized exercise program and physiotherapeutic treatment, according to clinical stability and functional assessment. The study exclusively focused on the in-hospital rehabilitation period and documented cardiac and non-cardiac complications, including the Hemocompatibility-Related Adverse Events (HRAEs). The Barthel index (BI) was used to assess functional recovery from admission to discharge. Results in a subgroup of 210 LVAD patients matched on a 1:1 basis with an HFrEF population were also analyzed.
One patient died during the inward rehabilitation period (respiratory failure). The majority (70.0%) of patients improved their disability (BI 67 ± 24 to 84 ± 23, p < 0.001). HRAEs occurred in 25 patients (9.1%). Compared to the HFrEF group, LVAD patients showed similar improvement in disability (p = 0.54).
The study suggests that an early intensive post-acute CR program can significantly improve functional capacity and disability in LVAD patients, similar to HFrEF patients admitted to the same program. Our data support scientific recommendations suggesting participation of LVAD to a CR.
植入左心室辅助装置(LVAD)是晚期慢性心力衰竭(CHF)患者的重要治疗选择。对于这些患者,转诊至早期、强化心脏康复(CR)计划的情况似乎仍未得到充分利用。这项观察性描述性研究旨在评估早期强化CR计划在LVAD植入患者中的可行性和疗效,并将结果与一组匹配的晚期射血分数降低的心力衰竭(HFrEF)患者进行比较。
该研究纳入了因HFrEF而植入LVAD的患者,这些患者于2009年至2023年从多个外科病房转入我们的强化急性后期CR计划。根据临床稳定性和功能评估,他们接受了每日两次的个体化运动计划和物理治疗。该研究仅关注住院康复期,并记录心脏和非心脏并发症,包括血液相容性相关不良事件(HRAEs)。采用Barthel指数(BI)评估从入院到出院的功能恢复情况。还分析了210例LVAD患者与HFrEF人群1:1匹配的亚组结果。
1例患者在住院康复期间死亡(呼吸衰竭)。大多数(70.0%)患者的残疾状况得到改善(BI从67±24提高到84±23,p<0.001)。25例患者(9.1%)发生了HRAEs。与HFrEF组相比,LVAD患者在残疾状况改善方面表现相似(p=0.54)。
该研究表明,早期强化急性后期CR计划可显著改善LVAD患者的功能能力和残疾状况,与参加同一计划的HFrEF患者相似。我们的数据支持科学建议,即LVAD患者应参与CR。